Muutke küpsiste eelistusi

Proteomics for Drug Discovery [Pehme köide]

Edited by
  • Formaat: Paperback / softback, 312 pages, kõrgus x laius: 254x178 mm, 58 Illustrations, color; 6 Illustrations, black and white
  • Sari: Methods in Molecular Biology
  • Ilmumisaeg: 26-Jul-2025
  • Kirjastus: Humana
  • ISBN-10: 1071639242
  • ISBN-13: 9781071639245
Teised raamatud teemal:
  • Pehme köide
  • Hind: 122,99 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 144,69 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 3-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
Proteomics for Drug Discovery
  • Formaat: Paperback / softback, 312 pages, kõrgus x laius: 254x178 mm, 58 Illustrations, color; 6 Illustrations, black and white
  • Sari: Methods in Molecular Biology
  • Ilmumisaeg: 26-Jul-2025
  • Kirjastus: Humana
  • ISBN-10: 1071639242
  • ISBN-13: 9781071639245
Teised raamatud teemal:
This detailed volume explores a wide range of experimental and bioinformatic proteomics methods applicable to the drug discovery process. Focused on drug target discovery, validation, characterization, and quantitation, the book delves into bottom-up data-dependent (DDA) shotgun and data-independent acquisition (DIA) proteomics, cell surface proteomics, proteogenomics, chemoproteomics, methodologies focused on posttranslational modifications, single cell proteomics, 3D cell culture proteomics, organoids, and laser capture microdissection (LCM) assisted tissue proteogenomics. Advanced quantitative techniques, which include label-free, mass tagging, and targeted immuno-MRM proteomics, along with top-down proteomics for validation and characterization of selected protein targets, are also described. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step and readily reproducible laboratory protocols, and tips on troubleshooting and avoiding foreseeable pitfalls.





 





Authoritative and practical, Proteomics for Drug Discovery serves as an ideal guide for researchers striving to push the field of drug discovery via MS-based proteomics to new frontiers.
A Multiplexed Single Cell Proteomic Workflow Applicable to Drug
Treatment Studies.- Systematic Identification of Kinase Substrates
Relationship by Integrated Phosphoproteome and Interactome Analysis.-
Quantitative Membrane Proteomics for Discovery of Actionable Drug Targets at
the Surface of RAS Driven Human Cancer Cells.- Using Photoreactive Probes to
Identify Viable Drug Targets in NonSmall Cell Lung Cancer.- A Microdissection
Protocol for Proteogenomic Analysis of Histological Sections to Advance Drug
Development.- Unbiased Quantitative Proteomics of Organoid Models of
Pancreatic Cancer.- Drug Screening Using Normal Cell and Cancer Cell Mixture
in an Automated 3D Cell Culture System.- Proteogenomic Workflow for
Characterization of Microphthalmia Transcription Factor (MiT) Family
Translocation Renal Cell Carcinoma.- A Tip Based Workflow for Sensitive IMAC
Based Low Nanogram Level Phosphoproteomics.- Microfluidic Sample Preparation
for Multiplexed Single Cell Proteomics Using a Nested Nanowell Chip.- 12 Plex
Isobaric Multiplex Labeling Reagents for Carbonyl Containing Compound (SUGAR)
Tag Enabled High Throughput Quantitative Glycomics.- Automated
Immunoprecipitation Workflow for Comprehensive Acetylome Analysis.- A Fast
Tracking Sample Preparation Protocol for Proteomics of Formalin Fixed
Paraffin Embedded Tumor Tissues.- Identification of Proteomic Biomarkers of
Acetaminophen Induced Hepatotoxicity Using Stable Isotope Labeling.- Reusing
Peptide Spectral Reference Libraries to Discover Putative Plasma Biomarkers
of Response to Cancer Chemotherapy.- Targeted Mass Spectrometry for
Quantification of Receptor Tyrosine Kinase Signaling.- Detection and
Quantitation of Endogenous Membrane-Bound RAS Proteins and KRAS Mutants in
Cancer Cell Lines Using 1D SDS PAGE LC-MS2.- Determining KRAS4B Targeting
Compound Specificity by Top Down Mass Spectrometry.